Company profile: RemeGenix
1.1 - Company Overview
Company description
- Provider of development stage biotechnology focused on the commercialization of disease-altering therapies.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to RemeGenix
Handl Therapeutics
HQ: Belgium
Website
- Description: Provider of a therapeutics platform to deliver transformative advanced medicines to the market.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Handl Therapeutics company profile →
Titan Pharmaceuticals
HQ: United States
Website
- Description: Provider of proprietary therapeutics and subdermal implant drug delivery solutions targeting serious medical disorders. Offerings include ProNeura, a continuous, long-term subdermal delivery platform for chronic conditions; Probuphine, a buprenorphine implant for maintenance treatment of opioid use disorder in clinically stable patients taking 8 mg or less of oral buprenorphine daily; and a nalmefene implant to prevent relapse after detoxification.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Titan Pharmaceuticals company profile →
Precision Neuroscience
HQ: United States
Website
- Description: Provider of brain-computer interface technology, including the Layer 7 Cortical Interface, a minimally invasive, high-resolution implant for recording and stimulating brain activity; Precision BioMEMS microfabrication of biocompatible microelectrode arrays and foundry services; machine learning software to translate neural data; and a fast, reversible surgical implantation technique.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Precision Neuroscience company profile →
Canbex Therapeutics
HQ: United Kingdom
Website
- Description: Provider of treatments for spasticity in multiple sclerosis (MS) and other disorders, targeting the debilitating symptom of involuntary spasms and stiffness of limbs and torso, with a lead programme focused on improving the lives of people with this serious and incurable disorder.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Canbex Therapeutics company profile →
Interactive Motion Technologies
HQ: United States
Website
- Description: Provider of robotic solutions for patients with neurological conditions, offering evidence-based InMotion Robots developed from medical engineering research at MIT’s Newman Laboratory for Biomechanics and Human Rehabilitation, tested by leading medical centers worldwide for 10 years in over 40 studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Interactive Motion Technologies company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for RemeGenix
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to RemeGenix
2.2 - Growth funds investing in similar companies to RemeGenix
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for RemeGenix
4.2 - Public trading comparable groups for RemeGenix
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →